Veterinary Injectable Devices Market to Reach USD 6.11 Billion by 2034, Growing from USD 3.56 Billion in 2025 - SRI

London, UK - September 2026 | Strategic Revenue Insights Inc. - Online pharmacies are reshaping access to veterinary injectable devices as pet healthcare becomes more digitally enabled, while rising pet ownership, animal disease prevalence, and the expansion of livestock care strengthen demand across veterinary settings.

https://www.strategicrevenueinsights.com/industry/veterinary-injectable-devices-market

The Veterinary Injectable Devices market was valued at USD 3.56 billion in 2025 and is projected to reach USD 6.11 billion by 2034, growing at a CAGR of 6.2% during 2026-2034. Lead analyst Rohan Mehta assesses the market through primary interviews with veterinarians, veterinary clinics, animal research institutes, veterinary hospitals, pharmacies, device manufacturers, and other relevant animal-health stakeholders, supported by secondary data across the covered regions.

Key Takeaways

Market scale: The market was valued at USD 3.56 billion in 2025 and is projected to reach USD 6.11 billion by 2034 at a CAGR of 6.2%.

Segment momentum: Veterinary Clinics are the largest end-user and Veterinary Hospitals are the largest distribution channel, while Infusion Pumps and Online Pharmacies are gaining traction.

Technology trend: Advances in veterinary technology are producing more precise and easier-to-use injectable devices, while telemedicine is creating opportunities for devices used in remote consultations.

Regional outlook: Asia Pacific and emerging markets offer substantial opportunities; India has the fastest named country CAGR at 8%, followed by China at 7%.

Competitive field: Zoetis Inc., Merck Animal Health, and Boehringer Ingelheim are among the leading named players.

Full report access: https://www.strategicrevenueinsights.com/industry/veterinary-injectable-devices-market

Digital Distribution and Precision Veterinary Care Expand the Market

The veterinary care landscape is being shaped by higher pet ownership and growing awareness of animal health, increasing the need for effective tools to treat and prevent animal diseases. The trend toward pet humanization is also encouraging greater spending on pet healthcare, supporting demand for advanced injectable devices.

Technology is changing device design and delivery. Advances are making injectable devices more precise and easier to use, while research and development is focused on improving drug-delivery accuracy and the experience of veterinarians and pet owners. Telemedicine is adding another opportunity by increasing demand for devices suitable for remote consultations.

Livestock care provides a parallel growth pathway as population growth increases demand for meat and dairy products and reinforces the need to maintain animal health and productivity. Investment in healthcare infrastructure and greater focus on animal welfare are also supporting adoption, particularly in emerging economies.

Market Segmentation

Product Type: Syringes and Needles are the most commonly used devices because of their ease of use and cost-effectiveness. Infusion Pumps are gaining popularity because they can deliver precise medication doses over a specified period, while specialized devices in the Others category are gaining traction as veterinary practices seek solutions for unique needs.

Animal Type: Companion Animals represent a significant portion of the market, supported by rising pet ownership, pet humanization, and growing awareness of pet health. Livestock Animals also represent a significant portion, driven by meat and dairy demand and the need to maintain animal health and productivity. The source does not specify a distinct fastest-growing animal type.

End-User: Veterinary Clinics represent the largest end-user segment, supported by increasing demand for veterinary care and awareness about animal health. Animal Research Institutes are also significant, while other users include veterinary hospitals and animal shelters. The source does not identify a distinct fastest-growing end-user.

Distribution Channel: Veterinary Hospitals represent the largest distribution channel, driven by demand for veterinary care and awareness about animal health. Online Pharmacies are gaining popularity because of convenience and increasing e-commerce adoption in the veterinary sector, while Retail Pharmacies remain a significant channel.

Regional Outlook

The market covers Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. The United States is the largest named country market at USD 1.2 billion with a 5% CAGR, supported by high pet ownership, advanced veterinary facilities, and major market players. Germany is valued at USD 800 million with a 4% CAGR, China at USD 600 million with a 7% CAGR, Brazil at USD 400 million with a 6% CAGR, and India at USD 300 million with the fastest named country CAGR of 8%. China and India benefit from expanding healthcare sectors, increasing pet ownership, and greater awareness of animal health, while Brazil is supported by its large livestock population and demand for meat and dairy products.

Competitive Landscape

The competitive landscape includes Zoetis Inc., Merck Animal Health, Boehringer Ingelheim, Elanco Animal Health, Bayer Animal Health, Ceva Santé Animale, Virbac, Vetoquinol, Dechra Pharmaceuticals, Neogen Corporation, and Heska Corporation. Zoetis is known for its extensive product portfolio and strong global presence; Merck Animal Health offers a broad range of veterinary products and services with a focus on research and development; Boehringer Ingelheim emphasizes research and development, animal health, and strategic partnerships; Elanco focuses on innovation and sustainability; and the other named companies are investing in research and development, advanced devices, strategic partnerships, and global expansion.

Market Restraints

Stringent regulatory requirements and the high cost of advanced veterinary devices can limit adoption and create barriers for smaller clinics and new market entrants. Competition from alternative drug delivery methods, including oral medications and topical treatments, may also affect demand for injectable devices.

Related Report:

https://www.strategicrevenueinsights.com/industry/medical-alert-personal-emergency-response-system-market

https://www.strategicrevenueinsights.com/industry/microneedle-drug-delivery-system-market

https://www.strategicrevenueinsights.com/industry/life-science-microscopy-device-market

https://www.strategicrevenueinsights.com/industry/life-science-products-market

https://www.strategicrevenueinsights.com/industry/pharmaceutical-stability-storage-market

https://www.strategicrevenueinsights.com/industry/pharmaceutical-supply-chain-security-market

https://www.strategicrevenueinsights.com/industry/oral-clinical-nutritional-supplement-market

https://www.strategicrevenueinsights.com/industry/hepatitis-c-virus-hcv-vaccine-market

https://www.strategicrevenueinsights.com/industry/ice-therapy-machines-market

https://www.strategicrevenueinsights.com/industry/cord-blood-banking-market

Frequently Asked Questions

What is the Veterinary Injectable Devices market size in 2025?

The market was valued at USD 3.56 billion in 2025.

What will the Veterinary Injectable Devices market be worth by 2034?

The market is projected to reach USD 6.11 billion by 2034, growing at a CAGR of 6.2% during 2026-2034.

What is driving the Veterinary Injectable Devices market?

Key drivers include increasing pet ownership, advancements in veterinary technology, growing awareness about animal health, the prevalence of animal diseases, and the rising adoption of home and telemedicine-enabled veterinary care.

Which companies are key players in the Veterinary Injectable Devices market?

Named key players include Zoetis Inc., Merck Animal Health, Boehringer Ingelheim, Elanco Animal Health, Bayer Animal Health, Ceva Santé Animale, Virbac, Vetoquinol, Dechra Pharmaceuticals, Neogen Corporation, and Heska Corporation.

Media Contact Information
Company Name: Strategic Revenue Insights Inc.
Contact Person: Rohit Bhisey
Email: sales@strategicrevenueinsights.com
Phone: +44 7877403352
Address: Suite 10, Capital House, 61 Amhurst Road, E8 1LL
City: London
State: London
Country: United Kingdom

About Strategic Revenue Insights Inc.

Strategic Revenue Insights Inc., a distinguished subsidiary of SRI Consulting Group Ltd, stands as a premier provider of data-driven market intelligence, empowering organizations globally to navigate complex business landscapes with confidence and precision. Headquartered in London, United Kingdom, our firm specializes in delivering comprehensive syndicated research reports, bespoke consulting solutions, and actionable strategic insights that enable clients to make informed, forward-thinking decisions in an increasingly competitive marketplace.

Our dedicated team of accomplished analysts, strategically positioned in London with an extensive global network, maintains continuous vigilance over evolving market dynamics, identifying emerging trends and uncovering high-potential growth opportunities that drive sustained client success. As an integral component of SRI Consulting Group Ltd, we uphold unwavering commitments to analytical accuracy, clarity of presentation, and practical applicability, assisting organizations in navigating competitive terrain, optimizing strategic initiatives, and accelerating revenue trajectories.

Through the integration of rigorous research methodologies with profound industry expertise, Strategic Revenue Insights Inc. delivers comprehensive market perspectives that generate measurable outcomes and establish enduring competitive advantages for our clients across diverse sectors and geographies.

Corporate Websites:
www.strategicrevenueinsights.com
www.strategicpackaginginsights.com
www.sriconsultinggroupltd.com
https://strategicrevenueinsights.blog/
https://medium.com/@strategic-revenue-insights.inc
https://www.strategicrevenueinsights.com/press-releases

This release was published on openPR.